Attention: This platform is in beta mode. Expect some changes and adjustments.

AI Market Mood: Stock Dashboard

ABSI


Fundamental

Company: Absci Corp
Sector: Healthcare
Industry: Biotechnology
Country: USA
Exchange: NASD
Index: RUT
P/E: -
EPS (ttm): -0.90
Insider Own: 9.47%
Shs Outstand: 149.75M
Perf Week: -5.38%
Market Cap: 383.45M
Forward P/E: -
EPS next Y: -0.67
Insider Trans: 0.72%
Shs Float: 136.13M
Perf Month: -23.88%
Enterprise Value: 220.85M
PEG: -
EPS next Q: -0.18
Inst Own: 70.07%
Short Float: 27.37%
Perf Quarter: -25.00%
Income: -114.60M
P/S: 136.46
EPS this Y: 12.37%
Inst Trans: 5.63%
Short Ratio: 9.35
Perf Half Y: -15.00%
Sales: 2.81M
P/B: 1.82
EPS next Y Percentage: 18.39%
ROA: -47.73%
Short Interest: 37.26M
Perf YTD: -26.93%
Book/sh: 1.40
P/C: 2.27
EPS next 5Y: 9.94%
ROE: -55.68%
52W High: 6.33 -59.72%
Perf Year: -49.00%
Cash/sh: 1.12
P/FCF: -
EPS past 3/5Y: 5.67% -29.30%
ROIC: -53.68%
52W Low: 2.01 26.87%
Perf 3Y: -2.67%
Dividend Est.: -
EV/EBITDA: -
Sales past 3/5Y: -1.76% 17.09%
Gross Margin: -331.55%
Volatility W: 7.55%
Volatility M: 7.31%
Perf 5Y: -
Dividend TTM: -
EV/Sales: 78.59
EPS Y/Y TTM: 3.38%
Oper. Margin: -4229.13%
ATR (14): 0.22
Perf 10Y: -
Dividend Ex-Date: -
Quick Ratio: 5.89
Sales Y/Y TTM: -33.09%
Profit Margin: -4071.19%
RSI (14): 38.29
Recom: 1.22
Dividend Gr. 3/5Y: - -
Current Ratio: 5.89
EPS Q/Q: 17.21%
SMA20: -10.61%
Beta: 2.15
Target Price: 8.05
Payout: -
Debt/Eq: 0.03
Sales Q/Q: -77.78%
SMA50: -21.83%
Rel Volume: 0.65
Prev Close: 2.42
Employees: 157
LT Debt/Eq: 0.02
Earnings: Nov 12 AMC
SMA200: -17.80%
Avg Volume: 3.99M
Price: 2.55
IPO: Jul 22, 2021
Option/Short: Yes / Yes
EPS/Sales Surpr.: 2.44% -76.07%
Trades:
Volume: 2,587,371
Change: 5.37%

Technical:


Latest News:

Analysts Have Conflicting Sentiments on These Healthcare Companies: AbSci (ABSI) and ... neutral
ABSI AMGN

Summary: Analysts weigh in on AbSci (ABSI) and Amgen (AMGN) in the Healthcare sector with price targets and ratings provided.

Full article
2024-05-20T15:43:14Z